H A R E S I G N

Primary care management consulting for GP practices and PCNs across England. IGPM Accredited Member.

Contact Info
Connect

LinkedIn

Primary care consulting for GP practices & PCNs across England. Get in touch →

Get In Touch

MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited)

Published
13 October 2026
Source
PSNC Dispensing & Supply News
Imported
13 Oct 2026

MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited) Drug alert number: EL(26)A/42 Date issued: 12 October 2026 Norgine Pharmaceuticals Limited is recalling the batches listed in the table due to risk of particulate matter being present in the product identified during routine stability investigations. DMRC reference number: DMRC-41054154 Company name: [...]

The post MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited) appeared first on Community Pharmacy England.

View Original Alert
Important: This alert is aggregated automatically for information only. Always refer to the original source and follow your practice's own clinical governance procedures.
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest

Back to Safety Alerts

Unlock your Practice Performance Overview

Register your practice for free to bring QOF, workforce, access, finance, contract and CQC data into a single live dashboard — benchmarked to national figures with an at-a-glance health score.